These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27158)

  • 1. Experiments on the preparations and testing of associated vaccine against foot and mouth disease and vesicular disease in swine.
    Mitev G; Tekerlekov P; Dilovsky M; Ognianov D; Nikolova E
    Arch Exp Veterinarmed; 1978; 32(1):29-33. PubMed ID: 27158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production, control and use in swine of anti-foot-and-mouth disease vaccine in oil adjuvant].
    Chappuis G; Brun A; Roulet C; Favre H; Terré J
    Dev Biol Stand; 1976; 35():139-48. PubMed ID: 198280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of immunity in swine vaccinated with foot-and-mouth disease vaccines prepared with various adjuvants].
    Mitev G; Tekerlekov P; Shopov I
    Vet Med Nauki; 1975; 12(1):16-22. PubMed ID: 1239851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 2. Use of foot-and-mouth 2-component oil emulsion vaccines in practice].
    Nöckler A; Thalmann G; Haack P; Nehmzow P; Poewe R; Pietzsch E; Seils G
    Arch Exp Veterinarmed; 1990; 44(2):183-8. PubMed ID: 2167045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Riems foot-and-mouth disease oil emulsion vaccines for swine. 1. Development and testing of highly effective and well-tolerated foot-and-mouth disease vaccine for swine using Dessauer oil adjuvants].
    Nöckler A; Thalmann G; Bartels T; Haack P
    Arch Exp Veterinarmed; 1990; 44(2):171-82. PubMed ID: 2167044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost.
    Li Y; Stirling CM; Denyer MS; Hamblin P; Hutchings G; Takamatsu HH; Barnett PV
    Vaccine; 2008 May; 26(21):2647-56. PubMed ID: 18321615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific immunoprophylaxis trials with calves against foot-and-mouth disease].
    Tekerlekov P; Uruchev K; Nikolova E; Genov I; Tsutsumanski V
    Vet Med Nauki; 1980; 17(2):28-35. PubMed ID: 6254238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats.
    Park ME; Lee SY; Kim RH; Ko MK; Lee KN; Kim SM; Kim BK; Lee JS; Kim B; Park JH
    Vaccine; 2014 Sep; 32(40):5221-7. PubMed ID: 25066738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency testing of foot--and--mouth disease vaccines prepared from strain "C" with different adjuvants.
    Sólyom F; Fazekas A; Czelleng F; Makár A; Roith J
    Dev Biol Stand; 1976; 35():113-5. PubMed ID: 198276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
    Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.